{"title":"[淋巴肉芽肿病的放疗]。","authors":"K H Hübener","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The status of radiotherapy of Hodgkin's disease is no longer determined by the staging alone but also by some special risk factors. So a marked improvement of curative radiotherapy becomes possible by close co-operation with chemotherapy, above all in patients with Bulky disease or with constellations having hitherto a considerably deteriorated prognosis in case of exclusive application of radiotherapy. The present study describes the different risk factors and submits the modified therapeutic procedure depending on the different stages.</p>","PeriodicalId":21981,"journal":{"name":"Strahlentherapie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1985-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Radiotherapy of lymphogranulomatosis].\",\"authors\":\"K H Hübener\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The status of radiotherapy of Hodgkin's disease is no longer determined by the staging alone but also by some special risk factors. So a marked improvement of curative radiotherapy becomes possible by close co-operation with chemotherapy, above all in patients with Bulky disease or with constellations having hitherto a considerably deteriorated prognosis in case of exclusive application of radiotherapy. The present study describes the different risk factors and submits the modified therapeutic procedure depending on the different stages.</p>\",\"PeriodicalId\":21981,\"journal\":{\"name\":\"Strahlentherapie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1985-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Strahlentherapie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Strahlentherapie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The status of radiotherapy of Hodgkin's disease is no longer determined by the staging alone but also by some special risk factors. So a marked improvement of curative radiotherapy becomes possible by close co-operation with chemotherapy, above all in patients with Bulky disease or with constellations having hitherto a considerably deteriorated prognosis in case of exclusive application of radiotherapy. The present study describes the different risk factors and submits the modified therapeutic procedure depending on the different stages.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
